References
- Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Youniss J, Rose SR, Borys D, May ME. 2002 Annual reports of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 2003; 21: 353–423
- Liebelt EL, Francis PD. Cyclic Antidepressants. Goldfrank's Toxicology Emergencies 7th, LR Goldfrank, NM Flomenbaum, NA Lewin, MA Howland, RS Hoffman, LS Nelson. McGraw-Hill Companies, New York 2002; 847–864
- Benowitz NL. Tricylic antidepresants. Poisoning and drug overdose 3rd, KR Olson. Appleton & Lange, Connecticut 1999; 310–312
- Lynge J, Hellsten Y. Distribution of adenosine A1, A2aand A2breceptors in human skeletal muscle. Acta Physiol Scand 2000; 169: 283–290
- Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990; 70: 761–845
- Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50(3)413–492
- Ramkumar V, Stiles GL, Beaven MA, Ali H. The A3adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993; 268: 16887–16890
- Kalkan S, Aygoren O, Akgun A, Gidener S, Guven H, Tuncok Y. Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats. J Toxicol Clin Toxicol 2004; 42: 945–954
- Prentice DJ, Hourani SMO. Activation of multiple sites by adenosine analogues in the rat isolated aorta. Br J Pharmacol 1996; 118: 1509–1517
- Pentel PR, Wananukul W, Scarlett W, Keyler DE. Nitric oxide contributes to desipramine-induced hypotension in rats. Hum Exp Toxicol 1996; 15: 320–328
- Tuncok Y, Kalkan S, Murat N, Arkan F, Guven H, Aygoren O, Kurt S. The effects of L-NAME on amitriptyline–induced hypotension in rats. J Toxicol Clin Toxicol 2002; 40: 121–127
- Dobson GP, Jones MW. Adenosine and Lignocaine: A new concept in non-depolarising surgical arrest, protection and preservation. J Thorac Cardiovasc Surg 2004; 127: 794–805
- Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol 1997; 79: 2–10
- Rongen GA, Brooks SC, Pollard MJ, Ando S, Dajani HR, Notarius CF, Floras JS. Effect of adenosine on heart rate variability in humans. Clin Sci 1999; 96: 597–604
- Bryan PT, Marshall JM. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1receptors. J Physiol 1999; 514: 151–162
- Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, Ongini E, Olsson RA, Dennis DM. The A2aadenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 1998; 284: 1066–1073
- Ngai AC, Coyne EF, Meno JR, West GA, Winn HR. Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J Physiol 2001; 280: 2329–2335
- Hinschen AK, Rose'Meyer RB, Headrick JP. Adenosine receptor subtypes mediating coronary vasodilation in rat hearts. J Cardiovasc Pharmacol 2003; 41: 73–80
- Dixon AK, Gubitz AK, Sirinathsinghji DJS, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996; 118: 1461–1468
- Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 2002; 283: 41–51
- Rubino A, Ralevic V, Burnstock G. Contribution of P1- (A2bsubtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed. Br J Pharmacol 1995; 115: 648–652
- Szentmiklo'si AJ, Ujfalusi A, Cseppento A, Nosztray K, Kovacs P, Szabo JZ. Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351: 417–425
- Dubey RK, Gillespie DG, Osaka K, Suzuki F, Jackson EK. Adenosine inhibits growth of rat aortic smooth muscle cells: Possible role of A2breceptor. Hypertension 1996; 27: 786–793
- Hannon JP, Pfannkuche HJ, Fozard JR. A role of mast cell in adenosine A3receptor-mediated hypotension in the rats. Br J Pharmacol 1995; 115: 945–952